Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Halimi

Showing results (11-20 of 233) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|October 17, 2003
Renal arterial resistance indexBruno Giraudeau, Jean-Michel Halimi
Current Hypertension Reports|March 13, 2009
ONTARGET: does dual blockade of the renin-angiotensin system provide more effective cardiovascular and renal protection in patients at high cardiovascular risk?Jean-Michel Halimi, Albert Mimran
The New England Journal of Medicine|December 28, 2022
Acute Decompensated Heart Failure, Volume, and AcetazolamideLaurent Fauchier, Valentin Maisons, Jean-Michel Halimi
The New England Journal of Medicine|February 18, 2010
Ankle-brachial index and peripheral arterial diseaseEmilie Vierron, Jean-Michel Halimi, Bruno Giraudeau
La Revue Du Praticien|April 1, 2003
[Proteinuria and nephrotic syndrome in the child and adult. Diagnostic orientation]Jean François Valentin, Jean-Michel Halimi, Hubert Nivet
Kidney International|September 22, 2023
Intussusception as a complication of idiopathic nephrotic syndromeFanny Dreant, Benedicte Sautenet, Christelle Barbet, et al.
Presse Medicale (Paris, France : 1983)|October 12, 2015
[Outcomes in randomized trials: Typology, relevance and importance for their standardization. Example of renoprotection]Bénédicte Sautenet, Jean Michel Halimi, Agnès Caille, et al.
Fundamental & Clinical Pharmacology|August 20, 2011
Renal endpoints in renal and cardiovascular randomized clinical trials: time for a consensus?Jean-Michel Halimi, Bénédicte Sautenet, Philippe Gatault, et al.
Diabetes Research and Clinical Practice|April 25, 2021
The impact of diabetes on heart failure development: The cardio-renal-metabolic connectionPaul Valensi, Gaétan Prévost, Sara Pinto, et al.
Cardiovascular Diabetology|April 3, 2023
Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)Pierre Gourdy, Patrice Darmon, François Dievart, et al.
Pageof 24

Showing results (11-20 of 233) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|October 17, 2003
Renal arterial resistance indexBruno Giraudeau, Jean-Michel Halimi
Current Hypertension Reports|March 13, 2009
ONTARGET: does dual blockade of the renin-angiotensin system provide more effective cardiovascular and renal protection in patients at high cardiovascular risk?Jean-Michel Halimi, Albert Mimran
The New England Journal of Medicine|December 28, 2022
Acute Decompensated Heart Failure, Volume, and AcetazolamideLaurent Fauchier, Valentin Maisons, Jean-Michel Halimi
The New England Journal of Medicine|February 18, 2010
Ankle-brachial index and peripheral arterial diseaseEmilie Vierron, Jean-Michel Halimi, Bruno Giraudeau
La Revue Du Praticien|April 1, 2003
[Proteinuria and nephrotic syndrome in the child and adult. Diagnostic orientation]Jean François Valentin, Jean-Michel Halimi, Hubert Nivet
Kidney International|September 22, 2023
Intussusception as a complication of idiopathic nephrotic syndromeFanny Dreant, Benedicte Sautenet, Christelle Barbet, et al.
Presse Medicale (Paris, France : 1983)|October 12, 2015
[Outcomes in randomized trials: Typology, relevance and importance for their standardization. Example of renoprotection]Bénédicte Sautenet, Jean Michel Halimi, Agnès Caille, et al.
Fundamental & Clinical Pharmacology|August 20, 2011
Renal endpoints in renal and cardiovascular randomized clinical trials: time for a consensus?Jean-Michel Halimi, Bénédicte Sautenet, Philippe Gatault, et al.
Diabetes Research and Clinical Practice|April 25, 2021
The impact of diabetes on heart failure development: The cardio-renal-metabolic connectionPaul Valensi, Gaétan Prévost, Sara Pinto, et al.
Cardiovascular Diabetology|April 3, 2023
Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)Pierre Gourdy, Patrice Darmon, François Dievart, et al.
Pageof 24